Skip to main content
Clinical Trials/KCT0008628
KCT0008628
Recruiting
未知

Assessment of Diagnostic Performance and Role of Ga-68 PSMA-11 PET/CT in Patients with Advanced Hepatocellular Carcinoma

Asan Medical Center0 sites50 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are older than19 years and capable of providing signatures in consent forms
  • \- Patients diagnosed with or suspected primary hepatocellular carcinoma by clinical information (blood test AFP, PIVKA elevation, etc.), imaging or pathology.
  • \- Patients with BCLC stage B or higher grade
  • \- Patients who have performed or are scheduled to perform tri\-phase abdominal pelvic CT within a four\-week period before Ga\-68 PSMA\-11 PET/CT and a two\-week period after Ga\-68 PSMA PET/CT after study enrollment
  • \- Patients who are willing to make a follow\-up observation in our hospital for at least 6 months after study enrollment

Exclusion Criteria

  • \- If other primary cancers other than liver cancer were previously diagnosed or occurred at the same time
  • \- Patients within 3 weeks after chemotherapy or within 4 weeks after hepatic artery chemoembolization
  • \- Patients are under severe and/or uncontrolled and/or unstable medical conditions (e.g., congestive heart failure, acute myocardial infarction, degenerative brain disease, severe lung disease, etc.)
  • \- Patients who cannot stably perform CT or PET/CT imaging tests due to claustrophobia, dyskinesia, anxiety disorders, and etc
  • \- Where it is determined that the patient will not be eligible to completely collect data for clinical trials due to personal circumstances or other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials